Baxter International | Salg Og Administrasjonskostnader



Selling And Administration Expenses Endring Dato
Abbott USD 2.91B 21M 2024-12
AtriCure USD 72.18M 1.05M 2024-12
Avanos Medical USD 79.6M 6.9M 2024-12
Baxter International USD 615M 16M 2024-12
Becton, Dickinson and Co. USD 1.32B 62M 2024-12
Boston Scientific USD 1.61B 50M 2024-12
Cooper Companies USD 387.9M 3.5M 2025-01
Dexcom USD 327.4M 21M 2024-12
Edwards Lifesciences USD 491.9M 70.5M 2024-12
Fresenius EUR 769M 68M 2024-12
Globus Medical USD 253.48M 12.74M 2024-12
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
ICU Medical USD 158.54M 3.88M 2024-12
Insulet USD 261M 26.9M 2024-12
Integra LifeSciences USD 169.62M 5.48M 2024-12
Intuitive Surgical USD 612.6M 102M 2024-12
J&J USD 6.45B 975M 2024-12
Laboratory Of America USD 595.2M 26.6M 2024-12
Masimo USD 223.4M 38.6M 2024-12
Medtronic USD 2.72B 34M 2025-01
Merit Medical Systems USD 102.57M 2.93M 2024-12
Quest Diagnostics USD 466M 34M 2024-12
Smith & Nephew USD 1.35B 12.8M 2024-12
Stryker USD 2.03B 229M 2024-12
Tandem Diabetes Care USD 105.84M 6.2M 2024-12
Teleflex USD 254.55M 7.3M 2024-12
Terumo JPY 96.35B 3.76B 2024-12
Zimmer Biomet Holdings USD 724.7M 18.8M 2024-12



Baxter International Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.